TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
This report contains market size and forecasts of Tuberculosis Diagnostic in Global, including the following market information:
The global Tuberculosis Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Radiographic Method Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tuberculosis Diagnostic include Thermo Fisher Scientific, Hologic Corporation, Abbott, Becton Dickinson, Roche, bioMerieux, Sanofi, Cepheid and Hain Lifescience and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tuberculosis Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tuberculosis Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Tuberculosis Diagnostic Market Segment Percentages, by Type, 2021 (%)
Global Tuberculosis Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Tuberculosis Diagnostic Market Segment Percentages, by Application, 2021 (%)
Global Tuberculosis Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Tuberculosis Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include: